# 2024-04-11--中药-济川药业-Q4业绩超预期，分红率再度提高_page1_图表2济川药业分季度财务指标变化单位百万元

|   | 2022-2Q | 2022-3Q | 2022-4Q | 2023-1Q | 2023-2Q | 2023-3Q | 2023-4 |
|---|--------|--------|--------|--------|--------|--------|-------|
| 营业收入 | 1,689.46 | 2,030.55 | 3,102.69 | 2,388.30 | 2,240.68 | 1,907.79 | 3,117.77 |
| 营收同比增长 | -4.33% | 17.58% | 39.67% | 9.87% | 32.63% | -6.05% | 0.49% |
| 营收环比增长 | -22.28% | 20.19% | 52.80% | -23.02% | -6.18% | -14.86% | 63.42% |
| 营业成本 | 304.08 | 369.72 | 520.10 | 429.36 | 420.72 | 346.56 | 587.35 |
| 营业费用 | 761.69 | 836.80 | 1,458.25 | 1,089.20 | 912.34 | 717.47 | 1,287.53 |
| 管理费用 | 89.75 | 88.15 | 108.21 | 83.88 | 96.99 | 98.08 | 93.83 |
| 财务费用 | -28.19 | -15.07 | -27.36 | -38.69 | -66.25 | -65.37 | -87.18 |
| 营业利润 | 495.32 | 666.76 | 650.95 | 760.34 | 771.14 | 692.50 | 1,033.45 |
| 利润总额 | 502.85 | 671.31 | 650.38 | 789.51 | 772.96 | 697.11 | 1,037.51 |
| 所得税 | 68.32 | 93.98 | 71.99 | 111.35 | 109.06 | 91.79 | 157.83 |
| 归母净利润 | 434.38 | 576.54 | 578.64 | 676.76 | 663.09 | 604.31 | 878.62 |
| 归母净利润同比增 | 4.73% | 37.89% | 29.39% | 16.44% | 52.65% | 4.82% | 51.84% |
| 净利率 | 25.71% | 28.39% | 18.65% | 28.34% | 29.59% | 31.68% | 28.18% |